Defensin: a multifunctional molecule lives up to its versatile name

Trends in Microbiology

Volumn 14, Issue 10, 2006, Pages 428-431

  Kim, Chun ^a,b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; ANTIBIOTIC AGENT; CELL PROTEIN; DEFENSIN; HUMAN NEUTROPHIL PROTEIN 1; HUMAN NEUTROPHIL PROTEIN 2; HUMAN NEUTROPHIL PROTEIN 3; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS ANTHRACIS; CORYNEBACTERIUM DIPHTHERIAE; HOST RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ALPHA-DEFENSINS; ANIMALS; BACTERIAL TOXINS; HUMANS; NEUTROPHILS; SIGNAL TRANSDUCTION;

BACTERIA (MICROORGANISMS);

EID: 33748569152     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2006.08.001     Document Type: Article

References (38)

1. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
2. Lehrer R.I., et al. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11 (1993) 105-128
3. Agerberth B., et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
4. Selsted M.E., et al. Primary structures of three human neutrophil defensins. J. Clin. Invest. 76 (1985) 1436-1439
5. Eisenhauer P.B., and Lehrer R.I. Mouse neutrophils lack defensins. Infect. Immun. 60 (1992) 3446-3447
6. Ganz T., et al. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76 (1985) 1427-1435
7. Yang D., et al. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68 (2000) 9-14
8. Aarbiou J., et al. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am. J. Respir. Cell Mol. Biol. 30 (2004) 193-201
9. Kim C., et al. Human α-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 4830-4835
10. Kim, C. et al. Human α-defensins neutralize toxins of the mono-ADP-ribosyltransferase family. Biochem. J. (in press). DOI:10.1042/BJ20060425 (www.biochemj.org).
11. Jin T., et al. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J. Immunol. 172 (2004) 1169-1176
12. Bokarewa M., and Tarkowski A. Human α-defensins neutralize fibrinolytic activity exerted by staphylokinase. Thromb. Haemost. 91 (2004) 991-999
13. Gudmundsson G.H., and Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J. Immunol. Methods 232 (1999) 45-54
14. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect. Immun. 55 (1987) 568-571
15. Bowdish D.M., et al. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6 (2005) 35-51
16. Yang D., et al. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
17. Bowdish D.M., et al. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77 (2005) 451-459
18. Lehrer R.I., et al. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84 (1989) 553-561
19. Hill C.P., et al. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251 (1991) 1481-1485
20. Nassar T., et al. Human α-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/α2-macroglobulin receptor. Blood 100 (2002) 4026-4032
21. Lillard Jr. J.W., et al. Mechanisms for induction of acquired host immunity by neutrophil peptide defensins. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 651-656
22. Tani K., et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int. Immunol. 12 (2000) 691-700
23. Oppenheim J.J., and Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17 (2005) 359-365
24. Collier R.J., and Young J.A. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19 (2003) 45-70
25. Okazaki I.J., and Moss J. Mono-ADP-ribosylation: a reversible posttranslational modification of proteins. Adv. Pharmacol. 35 (1996) 247-280
26. Corda D., and Di Girolamo M. Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci. STKE (2002) PE53
27. Paone G., et al. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8231-8235
28. Yates S.P., et al. Stealth and mimicry by deadly bacterial toxins. Trends Biochem. Sci. 31 (2006) 123-133
29. Gladysheva I.P., et al. Coevolutionary patterns in plasminogen activation. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9168-9172
30. Ganz T., et al. Defensins. Eur. J. Haematol. 44 (1990) 1-8
31. Panyutich A.V., et al. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J. Lab. Clin. Med. 122 (1993) 202-207
32. Ganz T., and Lehrer R.I. Defensins. Curr. Opin. Immunol. 6 (1994) 584-589
33. Charp P.A., et al. Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem. Pharmacol. 37 (1988) 951-956
34. Klotman M.E., and Chang T.L. Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6 (2006) 447-456
35. Chang T.L., et al. Dual role of α-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115 (2005) 765-773
36. Wang, W. et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J. Biol. Chem. (in press). DOI:10.1074/jbc.M603614200 (http://www.jbc.org)
37. Collier R.J. Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon 39 (2001) 1793-1803
38. Parry M.A., et al. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues. Trends Biochem. Sci. 25 (2000) 53-59